Dementia is one of the most serious neurodegenerative diseases, affecting millions of people worldwide. Although it is most commonly encountered in the elderly, it is also increasingly found in people under the age of 65, which experts refer to as early onset dementia. This disease causes a gradual decline in cognitive function, including mem...
Neuralink, a company that develops brain chips, has received approval from the US Food and Drug Administration (FDA) for its first clinical trial in humans, Reuters reports. This is a major milestone for Elon Musk's company, but volunteers cannot yet sign up for the study. Musk has predicted at least four times since 2019 that his Neuralink will...
